Therm-Core, a therapeutic application for the refinement of MRI techniques in oncology
Responsible for an estimated 9.6 million deaths in 2018, cancer is one of the leading causes of death in the world. The incidence is expected to reach 13 million in 2030. Therm-Core is a therapeutic application in which the Coretag probe is used in combination with MRI techniques.
The advantage of this application is the great precision and efficiency with which a tumor is destroyed. This Coretag technology creates new crucial medical solutions and a considerably better quality of care for millions of people with cancer.
As most cancer therapies have many adverse side-effects and are very expensive (immunotherapy up to $250,000 per treatment), there is a high unmet need for personalized medicine. Use of our technology will reduce side-effects and exert a potential life-saving effect.